Trade

with

Opko Health Inc
(NYSE: OPK)
AdChoices
8.36
+0.11
+1.33%
After Hours :
8.36
0.00
0.00%

Open

8.24

Previous Close

8.25

Volume (Avg)

1.27M (2.29M)

Day's Range

8.21-8.40

52Wk Range

7.32-11.64

Market Cap.

3.59B

Dividend Rate ( Yield )

-

Beta

0.99

Shares Outstanding

429.20M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 96.53M

    • Net Income

    • -114.41M

    • Market Cap.

    • 3.59B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -168.47

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.99

    • Forward P/E

    • -28.41

    • Price/Sales

    • 38.31

    • Price/Book Value

    • 3.91

    • Price/Cash flow

    • -40.16

      • EBITDA

      • -75.20M

      • Return on Capital %

      • -14.92

      • Return on Equity %

      • -23.84

      • Return on Assets %

      • -14.92

      • Book Value/Share

      • 2.14

      • Shares Outstanding

      • 429.20M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 11.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.30

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -1.20

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 59.20

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 43.83

            • 64.08

            • Pre-Tax Margin

            • -161.05

            • 15.19

            • Net Profit Margin

            • -168.47

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 40.00

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -110.30

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -98.50

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.13

              • 0.34

              • Current Ratio

              • 2.30

              • 2.55

              • Quick Ratio

              • 2.00

              • 1.83

              • Interest Coverage

              • -8.21

              • 11.70

              • Leverage Ratio

              • 1.45

              • 1.86

              • Book Value/Share

              • 2.14

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -23.15

                • 33.33

                • P/E Ratio 5-Year High

                • -35.21

                • 224.03

                • P/E Ratio 5-Year Low

                • -4.08

                • 60.23

                • Price/Sales Ratio

                • 38.91

                • 3.11

                • Price/Book Value

                • 3.98

                • 3.14

                • Price/Cash Flow Ratio

                • -40.16

                • 18.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -23.84

                    (-40.80)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • -14.92

                    (-22.20)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • -16.80

                    (-28.30)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • -

                  • 34.11k

                  • Inventory Turnover

                  • 2.57

                  • 2.77

                  • Asset Turnover

                  • 0.09

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -79.63M
                  Operating Margin
                  -82.49
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -40.16
                  Ownership

                  Institutional Ownership

                  94.71%

                  Top 10 Institutions

                  97.68%

                  Mutual Fund Ownership

                  8.91%

                  Float

                  53.77%

                  5% / Insider Ownership

                  8.07%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    3,676,509

                  • 0.00

                  • 0.86

                  • Vanguard Small Cap Index

                  •  

                    3,583,069

                  • -0.64

                  • 0.83

                  • Vanguard Total Stock Mkt Idx

                  •  

                    3,419,265

                  • 0.13

                  • 0.80

                  • iShares Russell 2000 (AU)

                  •  

                    3,092,147

                  • -0.63

                  • 0.70

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    2,421,836

                  • -2.53

                  • 0.56

                  • Vanguard Extended Market Index Fund

                  •  

                    2,091,812

                  • 2.37

                  • 0.49

                  • SPDR® S&P Biotech ETF

                  •  

                    1,989,723

                  • 0.60

                  • 0.45

                  • iShares Russell 2000 Growth

                  •  

                    1,444,497

                  • 0.77

                  • 0.33

                  • Fidelity® Contrafund® Fund

                  •  

                    1,430,900

                  • 0.00

                  • 0.33

                  • Fidelity Advisor® Biotechnology Fund

                  •  

                    791,951

                  • 0.00

                  • 0.18

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Frost Gamma Investments Trust

                  •  

                    155,608,105

                  • +58.61%

                  • 37.67

                  • Frost Phillip MD Et AL

                  •  

                    155,060,635

                  • +16.43%

                  • 46.04

                  • Frost Group LLC

                  •  

                    15,490,546

                  • 0.00%

                  • 3.75

                  • Vanguard Group, Inc.

                  •  

                    12,673,310

                  • -0.37%

                  • 2.98

                  • Orchard Hill Capital Management LLC

                  •  

                    7,326,900

                  • +1,489.35%

                  • 1.72

                  • BlackRock Fund Advisors

                  •  

                    5,754,634

                  • -0.46%

                  • 1.35

                  • Oracle Investment Management Inc

                  •  

                    5,655,738

                  • +1.50%

                  • 1.33

                  • State Street Corp

                  •  

                    4,851,827

                  • -5.39%

                  • 1.14

                  • Fidelity Management and Research Company

                  •  

                    4,468,460

                  • -7.45%

                  • 1.05

                  • Menora Mivtachim Life Insurance

                  •  

                    2,773,085

                  • +4.50%

                  • 0.65

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Distressed

                  Style

                  Small Growth

                  Opko Health Inc was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics, Inc. The Company is a multi-national biopharmaceutical and diagnostics company. It is developing various solutions to di...moreagnose, treat and prevent various conditions, including point-of-care tests, laboratory developed tests, molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It owns established pharmaceutical platforms in Chile, Spain, Mexico and Uruguay. It also has established pharmaceutical operations in Brazil. The Company owns a specialty active pharmaceutical ingredients manufacturer in Israel. The Company currently manages its operations in two reportable segments, pharmaceutical and diagnostics. The pharmaceutical segment consists of two operating segments,...more its (i) pharmaceutical research and development segment which is focused on the research and development of pharmaceutical products and vaccines, and (ii) the pharmaceutical operations it acquired in Chile, Spain, Mexico, Israel, Spain, Uruguay and Brazil. The diagnostics segment consists of two operating segments, the Companys (i) pathology operations it acquired through the acquisition of OPKO Lab and (ii) point-of-care and molecular diagnostics operations. Its main products Rayaldy and Alpharen are in phase 3 clinical development. Its competitors include diagnostic companies, reference laboratories, molecular diagnostic firms, universities and research institutions. The testing, manufacture, distribution, advertising, and marketing of drug and diagnostic products and medical devices are subject to extensive regulation by federal, state, and local governmental authorities in the U.S., including the FDA, and by similar agencies in other countries.lessless

                  Key People

                  Dr. Phillip Frost,M.D.

                  CEO/Chairman of the Board/Director

                  Dr. Arie Gutman

                  CEO, Divisional

                  Mr. Charles W Bishop, Pd.D

                  CEO, Subsidiary

                  Dr. Jane H. Hsiao, PhD

                  Chief Technology Officer/Director/Vice Chairman of the Board

                  Adam E. Logal

                  CFO/Senior VP

                  • Opko Health Inc

                  • 4400 Biscayne Boulevard

                  • Miami, FL 33137

                  • USA.Map

                  • Phone: +1 305 575-4100

                  • Fax: -

                  • opko.com

                  Incorporated

                  1991

                  Employees

                  625

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: